Cpex Pharmaceuticals, Inc.
Records under this name other than patents Cpex Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Cpex Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,320,968 | Pharmaceutical Composition Formerly held Term ended Term ended Jan 30, 2025 · High confidence | Term ended | Term ended Jan 30, 2025 | High confidence |
| US 7,651,996 | Pharmaceutical compositions and methods for insulin treatment Term ended Ended no later than Dec 2, 2024 · From the USPTO record | Term ended | Ended no later than Dec 2, 2024 | From the USPTO record |
| US 7,935,690 | Pharmaceutical Composition Formerly held Lapsed on the fee record Ended May 3, 2023 · High confidence | Lapsed on the fee record | Ended May 3, 2023 | High confidence |
| US 8,063,029 | Pharmaceutical Composition Formerly held Term ended Term ended Apr 21, 2023 · High confidence | Term ended | Term ended Apr 21, 2023 | High confidence |
| US 8,178,518 | Pharmaceutical Composition Formerly held Term ended Term ended Apr 21, 2023 · High confidence | Term ended | Term ended Apr 21, 2023 | High confidence |
| US 8,999,963 | Transdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome Formerly held Lapsed on the fee record Ended Apr 7, 2023 · From the USPTO record | Lapsed on the fee record | Ended Apr 7, 2023 | From the USPTO record |
| US 7,799,769 | Transdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome Formerly held Lapsed on the fee record Ended Sep 21, 2022 · From the USPTO record | Lapsed on the fee record | Ended Sep 21, 2022 | From the USPTO record |
| US 7,244,703 | Pharmaceutical compositions and methods for peptide treatment Term ended Term ended Aug 13, 2022 · From the USPTO record | Term ended | Term ended Aug 13, 2022 | From the USPTO record |
| US 7,816,318 | Pharmaceutical compositions and methods for peptide treatment Term ended Term ended Aug 9, 2022 · From the USPTO record | Term ended | Term ended Aug 9, 2022 | From the USPTO record |
| US 8,329,760 | Pharmaceutical composition Term ended Term ended Aug 4, 2022 · From the USPTO record | Term ended | Term ended Aug 4, 2022 | From the USPTO record |